These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30017958)

  • 1. HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries.
    Topazian HM; Kundu D; Peebles K; Ramos S; Morgan K; Kim CJ; Richter KL; Brewer NT; Peris M; Smith JS
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):575-582.e2. PubMed ID: 30017958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adolescent providers' knowledge of human papillomavirus vaccination age guidelines in five countries.
    Topazian HM; Dizon AM; Di Bona VL; Levitz L; Ramos S; Morgan K; Kim CJ; Richter K; De Sanjose S; Smith JS
    Hum Vaccin Immunother; 2019; 15(7-8):1672-1677. PubMed ID: 30625017
    [No Abstract]   [Full Text] [Related]  

  • 3. Persuasive messaging for human papillomavirus vaccination by adolescent providers in a five-country multi-site study.
    Rwamwejo J; Ramos S; Morgan K; Richter K; Kim CJ; Peris M; Smith JS
    Int J Gynecol Cancer; 2019 Feb; 29(2):250-256. PubMed ID: 30718309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries.
    Islam JY; Hoyt AM; Ramos S; Morgan K; Kim CJ; de Sanjose S; Butera N; Senkomago V; Richter KL; McDonald MA; Vielot NA; Smith JS
    Cancer Causes Control; 2018 Nov; 29(11):1115-1130. PubMed ID: 30284670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health Care Provider Perceptions of Facilitators and Barriers to Human Papillomavirus Vaccination Delivery in Five Countries.
    Islam JY; Gurbani A; Ramos S; Morgan K; Kim CJ; Richter KL; de Sanjose S; Smith JS; Vielot NA
    Sex Transm Dis; 2021 Aug; 48(8):557-564. PubMed ID: 34014055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices.
    Fokom Domgue J; Dille I; Kapambwe S; Yu R; Gnangnon F; Chinula L; Murenzi G; Mbatani N; Pande M; Sidibe F; Kamgno J; Traore B; Fazazi HE; Diop M; Tebeu PM; Diomande MI; Lecuru F; Adewole I; Plante M; Basu P; Dangou JM; Shete S
    Front Public Health; 2024; 12():1343064. PubMed ID: 38299075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar.
    Albayat SS; Mundodan JM; Elmardi K; Hasnain S; Khogali H; Baaboura R; Al-Romaihi HE; AlKubaisi NJ; Bougmiza MI
    Womens Health (Lond); 2024; 20():17455057241227360. PubMed ID: 38282514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of physicians' experiences with recommending HPV vaccines to adolescent boys.
    Wong LP; Edib Z; Alias H; Mohamad Shakir SM; Raja Muhammad Yusoff RNA; Sam IC; Zimet GD
    J Obstet Gynaecol; 2017 Oct; 37(7):937-943. PubMed ID: 28641049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model of health care provider decision making about HPV vaccination in adolescent males.
    Alexander AB; Best C; Stupiansky N; Zimet GD
    Vaccine; 2015 Aug; 33(33):4081-6. PubMed ID: 26143612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community.
    Javanbakht M; Stahlman S; Walker S; Gottlieb S; Markowitz L; Liddon N; Plant A; Guerry S
    Vaccine; 2012 Jun; 30(30):4511-6. PubMed ID: 22561142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study.
    Lim ASE; Lim RBT
    Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare providers' beliefs and attitudes regarding risk compensation following HPV vaccination.
    Kasting ML; Wilson S; Dixon BE; Downs SM; Kulkarni A; Zimet GD
    Papillomavirus Res; 2016 Dec; 2():116-121. PubMed ID: 27441302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia.
    Petagna CN; Perez S; Hsu E; Greene BM; Banner I; Bednarczyk RA; Escoffery C
    BMC Cancer; 2024 May; 24(1):592. PubMed ID: 38750439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.
    Berkowitz Z; Malone M; Rodriguez J; Saraiya M
    Prev Med; 2015 Dec; 81():405-11. PubMed ID: 26598805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of HPV vaccination uptake and opportunities for solutions: Lessons learned from Alabama.
    Dilley SE; Peral S; Straughn JM; Scarinci IC
    Prev Med; 2018 Aug; 113():124-131. PubMed ID: 29800594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with intention-to-recommend human papillomavirus vaccination among physicians in Mysore, India.
    Krupp K; Marlow LA; Kielmann K; Doddaiah N; Mysore S; Reingold AL; Madhivanan P
    J Adolesc Health; 2010 Apr; 46(4):379-84. PubMed ID: 20307828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provider factors associated with disparities in human papillomavirus vaccination among low-income 9- to 17-year-old girls.
    Vadaparampil ST; Staras SA; Malo TL; Eddleton KZ; Christie J; Rodriguez M; Giuliano AR; Shenkman EA
    Cancer; 2013 Feb; 119(3):621-8. PubMed ID: 23341308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths.
    Van Kriekinge G; Castellsagué X; Cibula D; Demarteau N
    Vaccine; 2014 Feb; 32(6):733-9. PubMed ID: 24291200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators.
    Morales-Campos DY; Flores BE; Donovan E; Burdick S; Parra-Medina D; Kahn JA
    BMC Public Health; 2022 Mar; 22(1):443. PubMed ID: 35248000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of multipurpose human papillomavirus vaccines among providers and mothers of adolescent girls: A mixed-methods study in five countries.
    Vielot NA; Goldberg SK; Zimet G; Smith SB; Anne McDonald M; Ramos S; Morgan K; Joo Kim C; Richter KL; Peris M; Whaley KJ; Smith JS
    Papillomavirus Res; 2017 Jun; 3():126-133. PubMed ID: 28720446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.